You have no items in your shopping cart.
- Mouse IL-18 [orb3002400]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.7 KDa. Observed: 20 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-1a [orb3002450]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18 KDa. Observed: 17 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μg - Mouse IL-1b [orb3002456]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.4 KDa. Observed: 16 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human IL-18 [orb3002413]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 18.2 KDa. Observed: 17 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Biotinylated Human IL-1a [orb3002217]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20 KDa. Observed: 19 KDa, reducing conditions
20 μg, 100 μg - Mouse IL-1R2 [orb3002218]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39 KDa. Observed: 45-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-1a [orb3002226]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.9 KDa. Observed: 54 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IL-1R2 [orb3002230]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.6 KDa. Observed: 50 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg
